This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schmelz, E. M. Articles by Merrill, A. H. Search for Related Content PubMed PubMed Citation Articles by Schmelz, E. M. Articles by Merrill, A. H., Jr.

Ceramide--D-Glucuronide

Synthesis, Digestion, and Suppression of Early Markers of Colon Carcinogenesis¹

Departments of Biochemistry [E. M. S., M. C. S., A. H. M.] and Chemistry [A. S. B., D. C. L.] and Department of Pathology and Division of Animal Resources [D. L. D.], Emory University, Atlanta, Georgia 30322-3050

Dietary sphingolipids inhibit chemically induced colon cancer in mice. The most likely mediators of this effect are the metabolites ceramide (Cer) and sphingosine, which induce growth arrest and apoptosis in transformed cells. Sphingolipids are digested in both the upper and the lower intestine; therefore, a more colon-specific method of delivery of sphingolipids might be useful. A Cer analogue with a D-glucuronic acid attached at the primary hydroxyl of N-palmitoyl-D-sphingosine (Cer--glucuronide) was synthesized and evaluated as a substrate for Escherichia coli -glucuronidase and colonic digestion, as well as for suppression of early events in colon carcinogenesis in CF1 mice treated with 1,2-dimethylhydrazine. Purified -glucuronidase (EC 3.2.1.31) and colonic segments (as a source of colonic enzymes and microflora) hydrolyzed Cer--glucuronide to release Cer, as analyzed by tandem mass spectrometry. More than 75% of the Cer--glucuronide was cleaved in an 8-h incubation with the colonic segments. When Cer--glucuronide was administered for 4 weeks as 0.025% and 0.1% of the diet (AIN 76A) to 1,2-dimethylhydrazine-treated mice, there were significant reductions in colonic cell proliferation, as determined by in vivo BrdUrd incorporation, and in the appearance of aberrant crypt foci. The effect of dietary Cer--glucuronide on aberrant crypt foci correlated significantly with the length of the colon, which suggests that Cer--glucuronide was most effective when there was a larger compartment for digestion. Thus, synthetic sphingolipids that target the colon for the release of the bioactive backbones offer a promising approach to colon cancer prevention.

This article has been cited by other articles:

				L. Guan, K. Song, M. A. Pysz, K. J. Curry, A. A. Hizli, D. Danielpour, A. R. Black, and J. D. Black Protein Kinase C-mediated Down-regulation of Cyclin D1 Involves Activation of the Translational Repressor 4E-BP1 via a Phosphoinositide 3-Kinase/Akt-independent, Protein Phosphatase 2A-dependent Mechanism in Intestinal Epithelial Cells J. Biol. Chem., May 11, 2007; 282(19): 14213 - 14225. [Abstract] [Full Text] [PDF]

				M. Moussavi, K. Assi, A. Gomez-Munoz, and B. Salh Curcumin mediates ceramide generation via the de novo pathway in colon cancer cells Carcinogenesis, August 1, 2006; 27(8): 1636 - 1644. [Abstract] [Full Text] [PDF]

				J. Wu, Y. Cheng, B. A. G. Jonsson, A. Nilsson, and R.-D. Duan Acid sphingomyelinase is induced by butyrate but does not initiate the anticancer effect of butyrate in HT29 and HepG2 cells J. Lipid Res., September 1, 2005; 46(9): 1944 - 1952. [Abstract] [Full Text] [PDF]

				D. Beaud, P. Tailliez, and J. Anba-Mondoloni Genetic characterization of the {beta}-glucuronidase enzyme from a human intestinal bacterium, Ruminococcus gnavus Microbiology, July 1, 2005; 151(7): 2323 - 2330. [Abstract] [Full Text] [PDF]

				J. Wu, Y. Cheng, A. Nilsson, and R.-D. Duan Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild-type enzyme in Caco-2 cells Carcinogenesis, August 1, 2004; 25(8): 1327 - 1333. [Abstract] [Full Text] [PDF]

				H. Symolon, E. M. Schmelz, D. L. Dillehay, and A. H. Merrill Jr. Dietary Soy Sphingolipids Suppress Tumorigenesis and Gene Expression in 1,2-Dimethylhydrazine-Treated CF1 Mice and ApcMin/+ Mice J. Nutr., May 1, 2004; 134(5): 1157 - 1161. [Abstract] [Full Text] [PDF]

				R.-D. Duan, T. Bergman, N. Xu, J. Wu, Y. Cheng, J. Duan, S. Nelander, C. Palmberg, and A. Nilsson Identification of Human Intestinal Alkaline Sphingomyelinase as a Novel Ecto-enzyme Related to the Nucleotide Phosphodiesterase Family J. Biol. Chem., October 3, 2003; 278(40): 38528 - 38536. [Abstract] [Full Text] [PDF]

				K. Yang, K. Fan, N. Kurihara, H. Shinozaki, B. Rigas, L. Augenlicht, L. Kopelovich, W. Edelmann, R. Kucherlapati, and M. Lipkin Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations Carcinogenesis, March 1, 2003; 24(3): 605 - 611. [Abstract] [Full Text] [PDF]

				Y. Cheng, A. Nilsson, E. Tomquist, and R.-D. Duan Purification, characterization, and expression of rat intestinal alkaline sphingomyelinase J. Lipid Res., February 1, 2002; 43(2): 316 - 324. [Abstract] [Full Text] [PDF]

				M. B. Hansen-Petrik, M. F. McEntee, B. Jull, H. Shi, M. B. Zemel, and J. Whelan Prostaglandin E2 Protects Intestinal Tumors from Nonsteroidal Anti-inflammatory Drug-induced Regression in ApcMin/+ Mice Cancer Res., January 1, 2002; 62(2): 403 - 408. [Abstract] [Full Text] [PDF]

				C. Sanchez, M. L. de Ceballos, T. G. del Pulgar, D. Rueda, C. Corbacho, G. Velasco, I. Galve-Roperh, J. W. Huffman, S. Ramon y Cajal, and M. Guzman Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor Cancer Res., August 1, 2001; 61(15): 5784 - 5789. [Abstract] [Full Text] [PDF]

				B. Ogretmen, D. Schady, J. Usta, R. Wood, J. M. Kraveka, C. Luberto, H. Birbes, Y. A. Hannun, and L. M. Obeid Role of Ceramide in Mediating the Inhibition of Telomerase Activity in A549 Human Lung Adenocarcinoma Cells J. Biol. Chem., June 29, 2001; 276(27): 24901 - 24910. [Abstract] [Full Text] [PDF]